Angiotensinogen promoter polymorphisms predict low diffusing capacity in U.S. and spanish IPF cohorts

Lung

Volumn 191, Issue 4, 2013, Pages 353-360

  Dang, My Trang T ^a   Gu, Chenyang ^b   Klavanian, Jeannie I ^b   Jernigan, Katherine A ^a   Friderici, Karen H ^a   Cui, Yuehua ^b   Molina Molina, Maria ^c   Ancochea, Julio ^d   Xaubet, Antoni ^e   Uhal, Bruce D ^b  

^a Michigan State University ^*  (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Angiotensin II; Fibrosing alveolitis; Interstitial lung disease

Indexed keywords

ANGIOTENSINOGEN;

ADULT; AGED; ARTICLE; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84880841006     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9476-2     Document Type: Article

References (28)

1. King TE, Pardo A, Selman M (2011) Idiopathic pulmonary fibrosis. Lancet 378(9807):1949-1961
2. Datta A, Scotton CJ, Chambers RC (2011) Novel therapeutic approaches for pulmonary fibrosis. Br J Pharmacol 163:141-172
3. Nicholson AG, Fulford LG, Colby TV, du Bois RM, Hansell DM, Wells AU (2002) The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 166:173-177
4. Weber KT, Sun Y (2000) Recruitable ACE and tissue repair in the infracted heart. J Renin Angiotensin Aldosterone Syst 1:295-303
5. Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H (2001) Angiotensin-II type I receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 34:745-7501
6. Klahr S, Morrissey JJ (1997) Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring. Kidney Int Suppl 63:S111-S114
7. Ko SH, Hong OK, Kim JW, Ahn YB, Song KH, Cha BY, Son HY, Kim MJ, Jeong IK, Yoon KH (2006) High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem 98:343-355
8. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms SE, Unger T, McAnulty RJ, Laurent GJ (2004) Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 286:L156-L164
9. Uhal BD, Kim JK, Li X, Molina-Molina M (2007) Angiotensin-TGF-β1 crosstalk in human idiopathic pulmonary fibrosis: autocrine mechanisms in myofibroblasts and macrophages. Curr Pharm Des 13:1247-1256
10. Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD (2000) Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 279:L143-L151
11. Li X, Rayford H, Uhal BD (2003) Essential roles for angiotensinogen receptor AT1a in belomycin-induced apoptosis and lung fibrosis in mice. Am J Pathol 163:2523-2530
12. Li X, Zhuang J, Rayford H, Zhang H, Shu R, Uhal BD (2007) Attenuation of bleomycin-induced pulmonary fibrosis by intratracheal administration of antisense oligonucleotides against angiotensinogen mRNA. Curr Pharm Des 13:1257-1268
13. Abdul-Hafez A, Shu R, Uhal BD (2009) JunD and HIF-1α mediate transcriptional activation of angiotensinogen by TGF-β1 in human lung fibroblasts. FASEB J 23:1655-1662
14. Yanai K, Saito T, Hirota K, Kobayashi H, Murakami K, Fukamizu A (1997) Molecular variation of the human angiotensinogen core promoter element located between the TATA box and transcription initiation site affects its transcriptional activity. J Biol Chem 272:30558-30562
15. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797
16. Goto S, Narita I, Saito N, Watanabe Y, Yamazaki H, Sakatsume M, Shimada H, Nishi S, Ueno M, Akazawa K, Arakawa M, Gejyo F (2002) A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int 62:980-985
17. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM, Jonsson JR (2000) Host genetic factors influence disease progression in chronic hepatitis. Hepatology 31:828-833
18. Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, O'Brien PE (2003) Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 39:967-971
19. Xiao F, Wei H, Song S, Li G, Song C (2006) Polymorphisms in the promoter region of the angiotensinogen gene are associated with liver cirrhosis in patients with chronic hepatitis B. J Gastroenterol Hepatol 21:1488-1491
20. Wu SJ, Chiang FT, Chen WJ, Liu PH, Hsu KL, Hwang JJ, Lai LP, Lin JL, Tseng CD, Tseng YZ (2004) Three single-nucleotide polymorphisms of the angiotensinogen gene and susceptibility to hypertension: single locus genotype vs. haplotype analysis. Physiol Genomics 17:79-86
21. Molina-Molina M, Xaubet A, Li X, Abdul-Hafez A, Friderici K, Jernigan K, Fu W, Ding Q, Pereda J, Serrano-Mollar A, Casanova A, Rodriguez-Becerra E, Morell F, Ancochea J, Picado C, Uhal BD (2008) Angiotensinogen -6G > A polymorphism influences idiopathic pulmonary fibrosis disease progression. Eur Respir J 32:1004-1008
22. Jeunemaitre X (1997) Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 60:1448-1460
23. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure of extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
24. Chapman CML, Palmer LJ, McQuillan BM, Hung J, Burley J, Hunt C, Thompson PL, Beilby JP (2001) Polymorphisms in the angiotensinogen gene are associated with carotid intimal-medial thickening in females from a community-based population. Atherosclerosis 159:209-217
25. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A (1991) Role of C/A polymorphism at -20 on the expression of human angiotensinongen gene. Hypertension 33:108-115
26. Gharaee-Kermani M, Hatano K, Nozaki Y, Phan SH (2005) Gender-based differences in bleomycin-induced pulmonary fibrosis. Am J Pathol 166:1593-1606
27. Narayanan CS, Cui Y, Zhao YY, Zhou J, Kumar A (1999) Orphan receptor Arp-1 binds to the nucleotide sequence located between TATA box and transcriptional initiation site of the human angiotensinogen gene and reduces estrogen induced promoter activity. Mol Cell Endocrinol 148:79-86
28. Hoshino K, Ishiguro H, Teranishi J, Yoshida S, Umemura S, Kubota Y, Uemura H (2011) Regulation of androgen receptor expression through angiotensin II type 1 receptor in prostate cancer cells. Prostate 71:964-975